NEW CUSTOMERS SAVE 40% W/AUTOSHIPUse code NEW40 (Up to $30 max. Exclusions apply)
SAVE AN EXTRA $5 - $20 OFFUse code PETS in cart (Exclusions apply)
Use code SAVE35 in cart
Up to $20 off, exclusions applyEnrofloxacin is a synthetic chemotherapeutic agent from the class of the quinolone carboxylic acid derivatives. Enrofloxacin Antibacterial Injectable Solution requires a prescription from your veterinarian
Dogs
Enrofloxacin Antibacterial Injectable Solution has antibacterial activity against a broad spectrum of Gram-negative and Gram-positive bacteria
The use of Enrofloxacin is contraindicated in small and medium-breed dogs during the rapid growth phase (between 2 and 8 months of age). The safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase.
For use in animals only. The use of this product in cats may result in Retinal Toxicity. Keep out of reach of children. Protect from direct sunlight. Do not freeze. Store at 68-77°F (20-25°C); excursions permitted between 15 and 30°C (59 and 86°F). Use within 90 days of the first puncture and puncture a maximum of 20 times. Any product remaining after 20 punctures or more than 90 days after the initial puncture should be discarded
Enrofloxacin (Dechra)
Enrofloxacin
Enrofloxacin is a synthetic chemotherapeutic agent from the class of the quinolone carboxylic acid derivatives. It has antibacterial activity against a broad spectrum of Gram-negative and Gram-positive bacteria. Each mL of injectable solution contains: enrofloxacin 22.7 mg, n-butyl alcohol 30 mg, potassium hydroxide for pH adjustment, and water for injection, q.s
Quinolone-class drugs should be used with caution in animals with known or suspected Central Nervous System (CNS) disorders. Tell your veterinarian if your pet has or may have any central nervous system disorders. In such animals, quinolones have, in rare instances, been associated with CNS stimulation which may lead to convulsive seizures
Enrofloxacin Injectable Solution may be used as the initial dose at 2.5 mg/kg. It should be administered intramuscularly (IM) as a single dose, followed by initiation of enrofloxacin tablet therapy
No drug-related side effects were reported in 122 clinical cases treated with enrofloxacin injectable solution followed by enrofloxacin tablets at 5.0 mg/kg per day
Consult your veterinarian
If you suspect that your pet has received an overdose of Enrofloxacin, consult your veterinarian or emergency veterinary clinic immediately.
Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for 15 minutes. In case of dermal contact, wash skin with soap and water. Consult a physician if irritation persists following ocular or dermal exposure. Individuals with a history of hypersensitivity to quinolones should avoid this product. In humans, there is a risk of user photosensitization within a few hours after excessive exposure to quinolones. If excessive accidental exposure occurs, avoid direct sunlight.
Concomitant therapy with other drugs that are metabolized in the liver may reduce the clearance rates of the quinolone and the other drug. Enrofloxacin has been administered to dogs at a daily dosage rate of 10 mg/kg concurrently with a wide variety of other health products including anthelmintics (praziquantel, febantel), insecticides (pyrethrins), heartworm preventatives (diethylcarbamazine) and other antibiotics (ampicillin, gentamicin sulfate, penicillin). No incompatibilities with other drugs are known at this time.
The initial enrofloxacin injectable administration should be followed 12 hours later by initiation of enrofloxacin tablet therapy
Weight | Dosage |
---|---|
20lbs | 1mL |
60lbs | 3mL |
Cats | Do not use! |
---|
Horses | Do not use! |
---|
Active Ingredients (per ml) | Amount |
---|---|
Enrofloxacin | 22.7 mg |
n-butyl alcohol | 30 mg |
Other Ingredients: potassium hydroxide for pH adjustment and water for injection, q.s. |